Abstract Since its introduction in the last decade, massive parallel sequencing, or "next-generation sequencing", has revolutionized our access to genomic information, providing accurate data with increasingly higher yields and lower costs with respect to first-generation technology. Massive parallel sequencing of cDNA, or RNA-seq, is progressively replacing array-based technology as the method of choice for transcriptomics. This review describes some of the most recent applications of next-generation sequencing technology to the study of pathogenic fungi, including Candida, Aspergillus and Cryptococcus species. Several integrated approaches illustrate the power and accuracy of RNA-seq for studying the biology of human fungal pathogens. In addition, the lack of consistency in data analysis is discussed.
Introduction
The development of next-generation sequencing technologies has probably had more impact on our understanding of fungal biology than any other eukaryotic species group. By 2012, the genomes of approximately 200 fungal species have been sequenced (www.fungalgenomes.org).
More recently, RNA-seq, or high-throughput cDNA sequencing technology, has been increasingly adopted as a method of obtaining large amounts of transcriptomic data with high sensitivity, high quality and at relatively low cost [1, 2] . The major advantages over the previously used microarrays are that no prior knowledge of the transcriptome is required; the high sensitivity allows a deeper characterization of the transcriptional landscape, including noncoding transcripts, rare and novel transcripts, fusion products and rare splicing isoforms [1] ; and strand-specific methods can be used to improve annotation and to identify antisense transcription [3] . The development of the technologies has been accompanied by significant advances in data analysis [4-6, 7••] .
In this review we describe the recent applications of genome sequencing and RNA sequencing to addressing important biological questions in major fungal pathogens.
Genomics of Pathogenic Fungi
The yeast Saccharomyces cerevisiae was the first eukaryotic genome to be fully sequenced, in 1996 [8] . Other notable landmarks followed, including the genomes of Candida albicans [9] and six other Candida species [10] , filamentous fungi including the aspergilli [11, 12] and basidiomycete species including Cryptococcus [13] . As new genome sequences became available, the application of comparative analysis allowed the identification of gene families with roles in fungal virulence [10] and the identification of potential new lead compounds for drug discovery [14] .
Candida species are among the most common fungi associated with hospital-acquired infection, particularly in immunocompromised individuals [15] . Whereas most infections are caused by C. albicans, other species such as Candida parapsilosis, C. tropicalis and the distantly related C. glabrata are increasing causes of concern [16•] . Comparison of the genomes of pathogenic Candida species with closely related nonpathogens shows that several gene families associated with virulence are expanded in the pathogens [10] . These include the ALS family of adhesins the Hyr/Iff family of cell wall proteins, and other less wellclassified families, many associated with the cell wall.
Comparisons of small numbers of closely related species can also contribute to our understanding of virulence. For example, comparing the genome of C. albicans with that of the substantially less pathogenic species Candida dubliniensis revealed that there has been substantial gene loss and pseudogenization (gene decay) in the latter species [17] . More recently, Riccombeni et al. [18• ] used next-generation sequencing to carry out a comparative analysis of C. parapsilosis and Candida orthopsilosis.
C. parapsilosis is the second most frequent cause of candidiasis in Latin America and is particularly common in Europe [19] . C. orthopsilosis is very closely related to C. parapsilosis, and was previously identified as a subgroup [20] . Despite their phenotypic similarity, C. orthopsilosis is a much less frequent cause of infection, and is responsible for between 1.4 % [21] and 23.8 % [22] of infections previously attributed to C. parapsilosis. Riccombeni et al. [18• ] used a combination of 454, Illumina and Sanger technologies to sequence the C. orthopsilosis genome. The eight chromosomal scaffolds encode 5,700 genes, of which 97.7 % have a direct ortholog in C. parapsilosis. The divergence time between C. parapsilosis and C. orthopsilosis is approximately twice that between C. albicans and C. dubliniensis. Comparison of the four species revealed that the WOR2 and CTA26/TLO2 regulators are evolving faster in C. albicans/C. dubliniensis than in C. parapsilosis/C. orthopsilosis. WOR2 is a global regulator of the white/opaque switch in C. albicans, a morphological change associated with virulence [23] , whereas TLO2 is a component of the mediator complex and is associated with the regulation of filamentation [24] . The rapid evolution of these two genes may be associated with the increased virulence of C. albicans.
Interestingly, there has been an expansion of the H + antiporter-1 (DHA1) and FLU1 clades of the major facilitator (MFS) family of drug transporters in C. parapsilosis and C. orthopsilosis with respect to other Candida species. This may be related to the ability of C. parapsilosis to rapidly acquire resistance to azole drugs [25] . In contrast, the Hyr/ Iff family is substantially reduced in the less pathogenic C. orthopsilosis genome [18•] . The dermatophyte fungi are major causes of superficial infections in human and animal hosts, where they grow within keratinized structures. Common infections include athlete's foot, ringworm and onychomycosis, and infection is particularly high in hot and humid countries [26•] . These species are particularly difficult to study because they grow very slowly under laboratory conditions. There is currently an ongoing large-scale project to sequence the genomes of seven dermatophyte species [26•] , with the data available from the Broad Institute web site (www.tinyurl.com/dermacomp7). Burmester et al. [27••] recently reported the analyses of the genomes of two of these, Arthroderma benhamiae and Trichophyton verrucosum, which infect rodents and cattle, respectively, and also cause disease in humans.
The two genomes were assembled using data from a combination of next-generation and first-generation sequencing technologies, and are highly colinear with only five major rearrangements. Although approximately 97 % of the genes have clear orthologs in both species, there are >200 open reading frames that are specific to only one and may be important for host-specificity.
The genomes of the two dermatophytes were compared to the closely related species Coccidioides posadasii and C. immitis, and the more distant relative Aspergillus fumigatus. All these five fungi contain substantial numbers of protease genes, but the dermatophytes are particularly protease-rich, with 235 putative proteases. In particular, the M35 (deuterolysin), M36 (fungalysin) and S8 (subtilisin) protease families are expanded in the dermatophytes, and several are secreted during growth on keratin. The protease expansion is likely to reflect the ability of these species to use keratin as the sole source of carbon and nitrogen.
The dermatophytes also have a different distribution of secondary metabolism gene clusters compared to their close relatives. Both species have a higher number of gene clusters than Coccidioides, mostly due to an increase in the number of genes encoding nonribosomal peptide synthetase (NRPS). One NRPS and an associated MFS drug transporter are specific to A. benhamiae, although it is unknown whether this affects virulence and/or host specificity. There are also differences in the type of polyketide synthase (PKS) genes; most PKS are reducing in the dermatophytes, whereas the majority are nonreducing in other ascomycetes, including Coccidioides species. The reducing PKS may be required for pigment formation, which is likely to be associated with virulence.
Abadio et al. [14] illustrated how the increasing availability of genome sequences might be used to identify new targets for antifungal drugs. They selected 55 genes that were shown experimentally to be essential in either C. albicans [28] or A. fumigatus [29] plus two non-essential genes that are important for cell viability within the host, KRE2 and ERG6 [30, 31] . Ten potential targets were selected among genes with orthologs in eight fungal pathogens (C. albicans, A. fumigatus, Cryptococcus neoformans, Paracoccidioides lutzii, Paracoccidioides brasiliensis, Blastomyces dermatitidis, C. immitis and Histoplasma capsulatum) and absent from the human genome. These were reduced to four (TRR1, RIM8, ERG6 and KRE2) using other criteria such as enzymatic activity, no auxotrophic phenotype, and accessibility in the cell. TRR1 is required for maintaining redox status in S. cerevisiae [32] and RIM8 is involved in a pathway regulating alkaline pH response [33] and in the activation of the yeast-hyphal morphological switch in C. albicans [34] . ERG6 encodes a sterol methyltransferase required for membrane permeability in C. albicans [31] , whereas KRE2 encodes a mannosyltransferase and is involved in N-linked glycosylation, cell adherence and virulence [35] . Homology modelling was used to predict the 3D structure of Trr1 and Kre2. The usefulness of this approach and its potential to reduce the huge costs of drug development [36] will become clearer in the future as the targets are virtually tested using chemical libraries.
Fungal genomes of pathogenic and nonpathogenic species will continue to be sequenced at a high rate, driven in particular by the 1000 Fungal Genomes Project (http://1000. fungalgenomes.org/home/). However, it is also likely that sequencing multiple isolates of a single species will be used more frequently to yield biological insights. Such approaches have been used to study genome variation, diversity and evolution in Saccharomyces and related species [37, 38] .
RNA-seq Analysis of Pathogenic Fungi
RNA-seq is still a new technology, and is slowly being applied to analysis of human fungal pathogens. It is generally used as a method for improving genome annotation, and is increasingly applied to analysis of differential gene expression. RNA-seq is likely to become the method of choice for transcriptome analysis in the next few years. We describe here some of the recent applications in Candida, Aspergillus and Cryptococcus species.
Candida albicans
RNA-seq analysis was first used to characterize the transcriptome of C. albicans under a variety of growth conditions, including hyphal induction, pH stress, oxidative stress, nitrosative stress and induction of cell wall damage [39•, 40•] . The analyses helped update the existing annotation and led to the characterization of 602 novel transcriptionally active regions (nTARs) that may represent noncoding or regulatory RNAs.
Nobile et al. [41••] subsequently used RNA-seq together with microarray analysis to further expand the identification of nTARs and to characterize the regulatory network required for biofilm formation. Biofilms are a community of microorganisms that grow on solid or liquid surfaces, such as indwelling medical devices, or host tissues. In C. albicans, biofilm formation is associated with a switch from predominantly yeast-like growth to hyphal or filamentous growth, followed by the production of an extracellular matrix [42] [43] [44] . Nobile et al. [41••] identified six transcription factors (BCR1, TEC1, EFG1, NDT80, ROB1 and BRG1) that are required for biofilm development, both in vitro and in vivo, using established rat models for catheter [45] and oral infection [46] . Using a combination of transcriptional profiling and chromatin immunoprecipitation (ChIP) experiments, they showed that the transcription factors and their targets belong to a single network that regulates the formation of biofilms. Each of the six regulators is a target of at least two of the others, and each also positively regulates its own transcription: the core network is therefore very tightly regulated. Their analysis indicated that the network evolved recently and is specific to C. albicans.
In contrast, Tierney et al. [47••] used RNA-seq to profile the response of both host and pathogen to infection. They followed the interaction of C. albicans with murine bone marrow-derived cells over a 2-hour time course, from initial fungal adhesion to early lysis of host cells. Over the entire time course, 545 genes from C. albicans and 240 genes from Mus musculus were differentially expressed, and were placed into clusters based on common transcriptional patterns. Five C. albicans genes and six M. musculus genes with roles in virulence or infection were selected to represent the clusters. A network model inferred from the data suggested that there are multiple interactions between C. albicans and mouse genes, including a hub represented by HAP3, a C. albicans transcription factor. The model predicted that HAP3 is repressed by murine PTX3, and that HAP3 in turn represses the mouse MTA2 gene. PTX3 encodes a pattern recognition receptor that has been shown to have an opsonin-like role in facilitating pathogen uptake by phagocytes [48] . In contrast, MTA2 is associated with the NuRD chromatin remodelling machine [49] and knockouts display embryonic lethality with severe developmental issues in survivors, including autoimmune disease [50] . The predicted interaction between fungal HAP3 and murine PTX3 was confirmed experimentally by showing that PTX3 is induced in bone marrow-derived macrophages at both the protein and RNA levels following infection with C. albicans, unless HAP3 is deleted. Expression of murine PTX3 is not induced by C. albicans cells carrying a knockout in CDA2, a putative chitin deacetylase with a binding motif for Hap3. Tierney et al. [47••] suggest that binding of Ptx3 to Candida cells alters the immune response of the host cells in a Hap3-dependent manner, which may involve a direct interaction between Hap3 in the fungus and Mta2 in the host.
This analysis illustrates the potential power of using RNA-seq to explore pathogen-host interactions; however, the approach is also limited by the size of the dataset, which can be overwhelming. Tierney et al. [47••] restricted their analyses to a small number of genes supported by previous experimental evidence, and focused on transcription factor "hubs". While a similar approach has been used to identify networks associated with drug resistance in Candida [51] , this method is only successful when previous experimental analyses are available emphasizing the need for supporting laboratory-based research.
Candida parapsilosis
The genome of C. parapsilosis was first sequenced in 2009 [10] together with several other pathogenic Candida species. In 2011, Guida et al. [52•] used RNA-seq to greatly improve the genome annotation and to characterize the transcriptional profile of C. parapsilosis across a variety of conditions, including temperature variations and oxygen levels. In total, 421 gene models were added to the previous annotation [10] , 318 were removed and 664 were edited. Changes included the identification of 422 introns in 387 genes. Two introns were identified in the 3′ UTR of the same gene, CPAR2_601470. These are the first 3′ introns described in Candida species, and suggest that a novel mechanism for regulating gene expression may be present. The RNA-seq data also provided evidence for at least 95 nTARs, suggesting that these are common in Candida species [39•].
Guida et al. also used RNA-seq and microarray analysis to determine the transcriptional response of C. parapsilosis to hypoxic conditions, such as those encountered during infection or in biofilms [53, 54] . Both technologies identified increased expression of genes involved in ergosterol metabolism, fatty acid synthesis and glycolysis, and decreased expression of respiratory genes. The overall response is conserved in most fungi [53] . The analysis also identified the transcription factor UPC2 as a major regulator of ergosterol synthesis and drug resistance genes. This role is conserved with C. albicans and S. cerevisiae [55, 56] .
Aspergillus
Among the several hundred Aspergillus species identified, A. flavus and A. fumigatus are most closely associated with human infection [57, 58] . A. flavus produces several mycotoxins, including aflatoxins, which are an important contaminant of many food crops, such as corn, cotton and peanuts [59] . Aflatoxins are also highly carcinogenic, and ingestion is associated with acute hepatic failure [60] . Genes involved in aflatoxin biosynthesis are found close together in the genome in secondary metabolite clusters, including PKS and NRPS genes [61] . Yu et al. [62] used RNA-seq to determine the transcriptional response of 55 secondary metabolite clusters in A. flavus to changes in temperature. Expression of 11 clusters, including the aflatoxin cluster, was induced at 30°C relative to 37°C. Most genes in the aflatoxin cluster were expressed at very low levels at the higher temperature.
However, the sensitivity of the technology revealed that the expression levels of the two transcriptional regulators of the cluster (aflR and aflS) were 5-24 times higher at 30°C, although previous microarray experiments had suggested that they were equally expressed at both temperatures [63] . It is therefore possible that downregulation of the cluster at 37°C may be associated with low levels of expression of aflS.
Gibbons et al. [64•] applied RNA-seq to the investigation of global transcription profiles of A. fumigatus. The authors compared the profiles of cells growing in liquid shake flasks (planktonic colonies) to those growing in aerial static conditions, where they form a biofilm surrounded by an extracellular matrix [65] . The authors found that 96 % of the 9,887 annotated genes were expressed in at least one condition; only 251 genes were uniquely expressed in biofilms, and only 175 in planktonic colony cultures. However, the differentially expressed genes were not randomly located throughout the genome but are significantly enriched towards the telomeres. Subsequent investigation revealed that these overlapped with secondary metabolite clusters, many of which were unregulated under the biofilm conditions. A similar telomeric distribution of differentially expressed genes was previously observed during an analysis of early stages of infection of mammalian hosts with A. fumigatus. Genes involved in cell wall metabolism, ergosterol synthesis, multidrug transport and glycosylation are also upregulated in biofilm cells, whereas glycolytic genes are downregulated. The gene expression changes are likely to be associated with dramatic changes in the cell wall, which may contribute to the drug-resistant phenotype of biofilm cultures.
RNA-seq has also been applied to transcriptional profiling of nonpathogenic Aspergillus species, including A. oryzae, a species historically associated with the Japanese food industry, whose genome was sequenced in 2005 [66] . In a similar analysis to that described above for C. parapsilosis, Wang et al. [67] used RNA-seq to greatly improve the annotation of the A. oryzae genome. They reported widespread alternate splicing, in about 8.5 % of all genes. Comparing the expression patterns of cells growing on solid agar to those growing in liquid cultures suggested that protein production is increased in cells grown on solid media. The authors also induced the unfolded protein response (UPR) by treatment with DTT, commonly activated by accumulation of unfolded proteins in the endoplasmic reticulum. Inducing UPR resulted in a significantly higher number of upregulated genes in cultures growing on solid media than in those growing in liquid media, suggesting that the efficiency of the response depends on the culture conditions.
Cryptococcus neoformans
Cryptococcus species are members of the Basidiomycete clade. Infection occurs through inhalation of spores, and cryptococcosis is particularly common in immunocompromised patients [68] . Infection may also spread to the brain where it causes cryptococcal meningitis [69] . The most common causative species are C, neoformans and C. gattii. One distinctive feature of these organisms is the presence of a polysaccharide capsule formed of glucuronoxylomannans [70] , which encapsulates the cell wall and is required for sexual development [71] and virulence [68, 72] . The capsule undergoes dramatic changes in size, particularly during infection [73] .
Haynes et al. [74••] used RNA-seq together with ChIPseq to characterize the transcriptional changes that occur during capsule growth. Several known signalling pathways had previously been linked to capsule formation, including the stress-induced cAMP pathway, regulation of ironsensing and the HOG pathway, although no integrated model had been proposed. Haynes et al. [74• •] first identified genes whose transcriptional level correlated with capsule size using microarray technology, and selected ADA2, proposed as part of the SAGA histone acetylation complex [75] , for subsequent investigation. They showed that Ada2 is required for capsule development and for virulence in a mouse model. To further characterize the role of ADA2, the gene expression of the wild-type and ada2 mutant in capsule-inducing and non-inducing conditions was determined using RNA-seq. Several members of the pheromone response pathway were downregulated in the ada2 mutant, consistent with the role of capsule growth in mating. Genes related to capsule growth were also downregulated in both growth conditions. RNA-seq was also used to determine the transcriptional profile of deletions of CIR1 and NRG1, which result in hypocapsular formation. The two transcriptional regulators also control sexual development [76] . Several genes required for capsule biosynthesis and for capsule regulation lie downstream of all three regulators.
To identify genes directly regulated by ADA2, the RNAseq data were integrated with the ChIP-seq analysis using antibodies specific for acetylated lysines (K9) on histone H3. Deleting ada2 resulted in an overall reduction in the level of H3K9 acetylation, particularly near the transcriptional start sites of genes regulated by Ada2. These included HXT1, CPL1 and UGT1, with known roles in capsule formation, GAT201, a positive regulator of capsule formation from the GATA family of transcription factors, and STE2, which encodes a mating pheromone receptor. Overall, the effects of ADA2 were mostly indirect, as only 3 % of genes had both differential expression and acetylation in the ada2 deletion mutant. It is likely that much of the response depends on eight transcription factors that are directly regulated by ADA2. The integrated approach taken by Haynes et al. [74••] illustrates the power and resolution of nextgeneration sequencing technologies.
Cryptococcus gattii
Unlike C. neoformans, C. gattii has only recently emerged as a pathogen in immunocompetent hosts. A wellcharacterized outbreak began on Vancouver Island, Canada, and subsequently spread to the Pacific [77] . Differences in virulence with respect to C. neoformans include an increased abundance of nodules (cryptococcomas) in the lungs and in brain and a slower response to treatment [78] .
At least four distinct lineages of C. gattii have been identified [79] ; however, the genome sequence is available for only two strains from two of the four lineages, isolated in Canada and Australia. To allow a more comprehensive [87] analyses, Chaturvedi and Nierman [80] proposed sequencing the genome and transcriptome of 12 isolates. The selected strains cover all four lineages from a wide geographical distribution, including Africa, India, and South and North America, and have been selected to provide a variety of suitable models of virulence as displayed in mice, rats and humans. Overall, the availability of these datasets would greatly enhance the ability to carry out comparative genomic analyses of Cryptococcus species, to identify targets for potential drugs and vaccines and to identify single nucleotide polymorphisms for molecular typing.
Conclusion
Next-generation sequencing technology has led to an explosion in the amount of genome data available; for example, in a single year the Sequence Read Archive grew larger than the previous 20 years of data in the older GenBank repository [81••] . Several hundred fungal genomes have been elucidated or are in progress (http://fungalgenome.org), and the amount of RNA-seq data sets is increasing. The most commonly used methodologies are based on largescale pyrosequencing (454 Life Sciences), ligation-based sequencing with di-base labelled probes (SOLiD) and sequencing by synthesis (Illumina) [82] , with others currently under development [81••] . One of the drawbacks of RNAseq is that data analysis can still be considered to be in a transitional phase. Even Illumina technology, benchmarked as the leading technology in 2010 [83] , lacks a standard method of analysis, and a standard method of normalization. The most common strategy is to use RPKM or FPKM (reads, or fragments, per kilobase of exon per million mapped sequence reads), introduced in 2008 by Mortazavi et al. [2] . More recent developments include the introduction of geometric mean normalization [4] and quantile normalization [84] .
In the last few years several open-source bioinformatic tools have been created to study differential gene expression through the quantification of RNA-seq data. These include the Tuxedo pipeline (including Cufflinks) [7••] and several R/Bioconductor packages such as DESeq [4] , baySeq [85] , DEGseq [86] and edgeR [87] . Some of these freely available tools have been integrated into the Galaxy project, an online environment designed to be used by experimental researchers with little computational background [5] . For the fungal genomics studies we describe here, no two groups used the same analysis strategy ( Table 1) . One of the priorities for the near future will be the emergence of a recognized standard, therefore increasing the reliability and our understanding of the vast amounts of information generated by next-generation sequencing.
Despite these outstanding issues, next-generation sequencing has already made important contributions to our understanding of fungal virulence. The continued application of RNA-seq to fungal species in parallel with sequencing of new genomes and new strains will greatly increase our understanding of the physiology of the pathogens, as well as the interaction between pathogens and host.
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